BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Outlook Therapeutics Confirms Status of Biologics License Application (BLA) Submission for ONS-5010

  Outlook Therapeutics reiterates expected re-submission of BLA by September 2022 following receipt of additional correspondence from U.S. Food and Drug Administration (FDA).

  June 14, 2022

   · 

  5 min read
• Biotech Beach

  aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

  Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform.

  June 14, 2022

   · 

  5 min read
• Drug Development

  HUYABIO INTERNATIONAL ANNOUNCES INITIATION OF HBI-3000 PHASE 2 TRIAL

  HUYABIO International today announced that the first three patients had been dosed in an ongoing Phase 2 study of HUYABIO’s novel drug for pharmacological cardioversion of atrial fibrillation (AF).

  June 14, 2022

   · 

  2 min read
• Biotech Beach

  Biological Dynamics Selected as Finalist for the 2022 AACC Disruptive Technology Award

  Award Recognizes the Company’s Verita ™ Isolation Platform, which Enables Early-Stage Cancer Detection.

  June 14, 2022

   · 

  2 min read
• Pharvaris Announces Annual Meeting of Shareholders - June 14, 2022

  Pharvaris announced the annual general meeting of shareholders will take place on Wednesday, June 29, 2022, at 16:00 CEST.

  June 14, 2022

   · 

  1 min read
• Pharm Country

  Applied UV Installs Patented LumiCide Surface Disinfection Solution into NYC’s Mt. Sinai Medical Center Morningside

  Applied UV, Inc. and automatically, announces that its wholly owned subsidiary SteriLumen has just installed its patented LumiCide Surface and Drain UVC Disinfecting Systems initially, in 17 patient rooms within the world renowned Mt. Sinai Medical Center Morningside.

  June 14, 2022

   · 

  7 min read
• Business

  Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic and to Accelerate Development of New Product Candidates from its Targeted Myeloid Engager and Phagocytosis Platform

  Momentum continues to build for Dren Bio after successfully forming highly experienced senior leadership team and earlier this year announcing research collaboration and license deal with Pfizer.

  June 14, 2022

   · 

  7 min read
• Business

  MedX Health Adds New Board Member

  MedX appoints Naman Demaghlatrous to its Board of Directors.

  June 14, 2022

   · 

  5 min read
• Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa

  The South African Health Products Regulatory Authority has approved a sweet-tasting, heat-stable, ‘4-in-1' fixed-dose combination of four antiretroviral treatments composed of abacavir, lamivudine, lopinavir, and ritonavir that is specifically designed for infants and young children with HIV.

  June 14, 2022

   · 

  6 min read
• Business

  Moderna Appoints DXTRA Health Integrated Solutions as Global Corporate AOR

  DXTRA Health Integrated Solutions has been appointed by Moderna as the brand’s global enterprise agency of record.

  June 14, 2022

   · 

  2 min read